BIOMAT Database Logo BIOMAT Database Logo

QT-interval prolongation with Ecstasy. 1996

W M Drake, and P A Broadhurst

UI MeSH Term Description Entries
D008297 Male Males
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015104 3,4-Methylenedioxyamphetamine An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. 3,4 Methylenedioxyamphetamine
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

W M Drake, and P A Broadhurst
QT interval prolongation.
January 1985, The Journal of emergency medicine,
W M Drake, and P A Broadhurst
Multifactorial QT interval prolongation.
January 2010, Cardiology journal,
W M Drake, and P A Broadhurst
Experimental QT interval prolongation.
January 1992, Annals of the New York Academy of Sciences,
W M Drake, and P A Broadhurst
Hereditary prolongation of QT interval.
July 1972, British heart journal,
W M Drake, and P A Broadhurst
Rivastigmine and QT interval prolongation.
June 2003, The British journal of psychiatry : the journal of mental science,
W M Drake, and P A Broadhurst
QT interval prolongation and beyond.
October 2006, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc,
W M Drake, and P A Broadhurst
What is QT interval prolongation?
June 2005, The Journal of family practice,
W M Drake, and P A Broadhurst
Aliskiren-induced QT interval prolongation.
April 2009, Southern medical journal,
W M Drake, and P A Broadhurst
Tamoxifen-induced QT interval prolongation.
August 2008, Journal of clinical pharmacy and therapeutics,
W M Drake, and P A Broadhurst
Drug-induced QT interval prolongation.
September 1996, British journal of clinical pharmacology,
Copied contents to your clipboard!